Author: | Pierre Theroux | ISBN: | 9781437721492 |
Publisher: | Elsevier Health Sciences | Publication: | September 24, 2010 |
Imprint: | Saunders | Language: | English |
Author: | Pierre Theroux |
ISBN: | 9781437721492 |
Publisher: | Elsevier Health Sciences |
Publication: | September 24, 2010 |
Imprint: | Saunders |
Language: | English |
Acute Coronary Syndromes-a Companion to Braunwald’s Heart Disease-covers the state-of-the-art scientific and clinical information you need to rapidly evaluate and manage acute coronary syndromes. Dr. Pierre Theroux and his team of expert contributors present advances in diagnostic and imaging techniques such as biomarkers, nuclear cardiology, echocardiography, and multislice CT; secondary prevention; and new antiplatelet, anti-ischemic, and gene therapies…in print and online.
Effectively handle the treatment of special populations and chronic patients thanks to coverage of these challenges
Integrate the latest testing and treatment techniques into your practice thanks to new chapters on biomarkers in acute ischemic heart disease; the role of noninvasive testing in prognostic risk stratification; the culprit lesions and patient at risk; non-responsiveness to antiplatelet therapy; bleeding in the acute coronary syndromes; and the refractory patient.
Acute Coronary Syndromes-a Companion to Braunwald’s Heart Disease-covers the state-of-the-art scientific and clinical information you need to rapidly evaluate and manage acute coronary syndromes. Dr. Pierre Theroux and his team of expert contributors present advances in diagnostic and imaging techniques such as biomarkers, nuclear cardiology, echocardiography, and multislice CT; secondary prevention; and new antiplatelet, anti-ischemic, and gene therapies…in print and online.
Effectively handle the treatment of special populations and chronic patients thanks to coverage of these challenges
Integrate the latest testing and treatment techniques into your practice thanks to new chapters on biomarkers in acute ischemic heart disease; the role of noninvasive testing in prognostic risk stratification; the culprit lesions and patient at risk; non-responsiveness to antiplatelet therapy; bleeding in the acute coronary syndromes; and the refractory patient.